Exosome Diagnostics Partners with Intezyne to Develop Exosomal RNA-based Assay for Novel Cancer Resistance Pathway (CRP) Inhibitor

World News: . []

Exosome Diagnostics Inc a market leader in liquid biopsy and the world’s first exosome-based diagnostics company announces a collaboration agreement with Intezyne Inc to design and validate a highly sensitive exosomal RNA based assay for use in Inte...

More news and information about Exosome Diagnostics

Published By:

Globe Newswire: 11:30 GMT Wednesday 14th March 2018

Published: .

Search for other references to "exosome" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us